Oral medication for Pyorrhoea
Phase 4
- Conditions
- Health Condition 1: A488- Other specified bacterial diseases
- Registration Number
- CTRI/2019/05/019281
- Lead Sponsor
- Triveni Institute of Dental Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Systemically healthy patients with the age range of 30 to 60 years
Presence of 12 or more scorable teeth
Atleast 30% of teeth having pocket dept of 5 mm or more
Clinical attachment loss to be moderate to severe
Gingival index of 1 or more
Plaque index of 1.5 or more
Exclusion Criteria
Subjects with any systemic illness
Smokers or tobacco chewers
Pregnant or lactating mothers
Patients with prosthesis or orthodontic applicance
Patients on medications like antibiotics antioxidants
History of periodontal treatment in past 3 months prior to study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in pocket depth,attachment loss and gingival inflammation with usage of lycopeneTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Improvement in salivary uric acid levels after scaling rootplaning and lycopene therapyTimepoint: 4 weeks